Isoflurane anesthesia in humans markedly decreases the threshold temperature triggering peripheral thermoregulatory vasoconstriction (i.e., central temperature triggering vasoconstriction). However, it is not known whether the sweating threshold remains unchanged (e.g., near 37"C), decreases along with the vasoconstriction threshold, or increases during anesthetic administration. Accordingly, the hypothesis that isoflurane anesthesia increases the thermoregulatory threshold for sweating was tested. Forehead sweating was evaluated in five healthy patients given isoflurane anesthesia. The sweating threshold was prospectively defined as the distal esophageal temperature at which significant sweating was first observed. Sweating was observed in each patient at a mean central temperature of 38.3 * 0.3"C and an end-tidal isoflurane concentration of 1.1% 2 0.2%. The interthreshold range (difference between vasoconstriction and sweating thresholds) without anesthesia is -0.5"C; isoflurane anesthesia increases this range to -4°C.
egulatory responses to hypothermia and hyperthermia can be defined in terms of thresholds R (central temperatures triggering protective actions) (1). In anesthetized, paralyzed patients, only cutaneous vasoconstriction and nonshivering thermogenesis are available defenses against hypothermia. Halothane (2), isoflurane (>5), and fentanyl-nitrous oxide (6) anesthesia inhibit central thermoregulatory peripheral cutaneous vasoconstriction. Although nonshivering thermogenesis is an important source of metabolic heat in anesthetized infants (Bissonnette B, Sessler DI, unpublished data) , oxygen consumption does not increase in hypothermic adults (7).
Anesthetized patients may respond to hyperthermia with active vasodilation and sweating. From the vasoconstriction data, it was not possible to determine whether the sweating threshold remained unchanged (e.g., near 37"C), decreased along with the vasoconstriction threshold, or increased during anesthetic administration. However, sweating is rarely observed at the normal or hypothermic central temperatures typical during surgery. Therefore, the hypothesis that the thermoregulatory threshold for sweating is elevated by isoflurane anesthesia was tested.
Methods
With approval from the Committee on Human Research of the University of California, San Francisco, the sweating threshold was measured in five ASA physical status I patients scheduled for peripheral microvascular surgery. None was obese, was taking medication, or had a history of thyroid disease, dysautonomia, Raynaud's syndrome, or malignant hyperthermia.
Without any preanesthetic medication, anesthesia was induced using 4-5 mgikg of thiopental and up to 500 pg of fentanyl. Rapid-sequence tracheal intubation with cricoid pressure was facilitated by intravenous administration of 100 mg of succinylcholine. Anesthesia was maintained with isoflurane (1%-1.4% end-tidal concentration) in oxygen, and the patients' lungs were mechanically ventilated to maintain endtidal CO, at 35-40 mm Hg. Respiratory gases were administered via a partially rebreathing circle system. Gas concentrations were quantified using a mass spectrometer (Medspect, St. Louis, Mo.) or a Datex Capnomac end-tidal gas analyzer (Datex Medical Instrumentation, Tewksbury, Mass.). The Capnomac analyzer was calibrated using a known mixture of gases before each study. heat and moisture exchanger between the Y-piece of the circle system and the endotracheal tube. Approximately 1 L of room-temperature lactated Ringer's solution was administered during each anesthetic study. Isoflurane and fluid administration were adjusted to maintain systolic arterial blood pressure near 100 mm Hg.
To increase peripheral blood flow and to facilitate microvascular repairs, the surgeons in each case requested that central temperature be increased to 38"-39"C. A full-length Bair Hugger cover (Augustine Medical, Eden Prairie, Minn.) was placed directly over each patient, then covered with a cotton blanket. The cover was inflated using a model 200 Bair Hugger warmer set on "high." We have previously demonstrated that this system transfers -50 W across the skin surface and will raise mean body temperature -1.5"C/h (8). The patient's entire head remained exposed to the ambient environment, which was maintained near 23°C.
Central temperature was measured in the esophagus using Mon-a-Therm model 6500 thermometers (St. Louis, Mo.); the thermocouple probe was incorporated into a disposable esophageal stethoscope and positioned at the distal end of the range of maximal heart sounds. Distal esophageal temperature correlates well with tympanic membrane temperature (9).
At 10-min intervals (starting after induction of anesthesia), forehead sweating was qualitatively evaluated: a sweating grade of 0 was assigned when no moisture could be detected, a grade of 1 when some moisture was detected, and a grade of 2 when distinct beads of sweat were visible. The forehead was swabbed dry using a gauze pad immediately after each sweating evaluation. Sweating was evaluated on the exposed forehead because sweating intensity may be increased slightly by local cutaneous warming (10,ll).
Grade 2 sweating was prospectively defined as significant, and the central temperature at which significant sweating was detected was considered the thermoregulatory threshold for sweating. All data are presented as mean ? standard deviations.
Results
The mean age of patients was 46 t 15 yr, and weight 74 f 11 kg. During induction of anesthesia, patients were given 338 ? 138 mg (range, 200-500) of sodium thiopental and 163 ? 236 pg (range, 0-500) of fentany 1.
Grade 2 sweating was observed in each patient 235 ? 126 min (range, 120430) after induction of anesthesia at a central temperature of 38.3 ? 0.3"C (range, 38.G38.7). At that time, the end-tidal isoflurane concentration was 1.1% f 0.2% (range, 1.0-1.4) SESSLER SWEATING THRESHOLD DURING ISOFLURANE ANESTHESIA 301 and the end-tidal CO, partial pressure was 37 ? 2 mm Hg.
Discussion
Thermoregulatory responses can be modeled using the engineering terms threshold and gain. The threshold for a particular regulatory effector is defined as the central temperature triggering that response. Gain quantifies the intensity of the response as central temperature further deviates from the triggering threshold (1). The difference between the temperatures triggering responses to hypothermia (e.g., vasoconstriction, shivering) and hyperthermia (e.g., active vasodilation, sweating) is called the in terthreshold range. Temperature changes within the interthreshold range are probably easily detected by the thermoregulatory system (12) but do not provoke physiologic responses. In normal, unanesthetized individuals, this range is only -0.5"C (13).
The patients in this study started to sweat at a central temperature of 38.3 ? 0.3"C while receiving 1.1% ? 0.2% isoflurane. This increase in the sweating threshold was caused by an isoflurane concentration known to decrease the threshold triggering vasoconstriction by -3.3"C (3). Thus, the interthreshold range increased from -0.5"C to -4°C. Within this range, anesthetized patients will be poikilothermic; their central temperatures will vary as a result of redistribution of heat within the body and alterations in metabolic heat production and heat loss to the environment. However, thermoregulatory responses during 1.1% isoflurane anesthesia will occur at central temperatures above 38.3 ? 0.3"C or below -33.7"c.
Isoflurane anesthesia caused a considerably smaller increase in the sweating threshold than decrease in the threshold for vasoconstriction ( -3.1°C/% isoflurane) (3). Teleologically, an aggressive sweating response is appropriate because hyperthermia is more dangerous than comparable hypothermia. Similar asymmetrical widening of the interthreshold range is typical in animals given chloralose-urethane, ethanol, pentobarbital, and morphine (14-20). Sweating was commonly observed during hyperthermic surgery (in tropical environments, before air-conditioning was available) and usually limited central temperatures to 139°C (21).
Isoflurane anesthesia does not impair the intensity of thermoregulatory vasoconstriction (once triggered) (3,5). Although this study did not quantify intensity (i.e., gain) of the sweating response, the intensity was high and the onset easily detected. Despite being covered by a warmer transferring -50 W across the skin via convection and radiation (8), the patients' central temperatures either remained constant or decreased after sweating started. Effective hyperthermia prevention is consistent with the observation that well-hydrated, unanesthetized humans in a dry, convective environment can lose five times their basal metabolic rates by sweating (13). (Shivering, in contrast, usually only doubles basal heat production [22, 23] .) It is such evaporative heat loss that allows humans to live safely at ambient temperatures exceeding 37°C.
Sweating during anesthesia can indicate inadequate anesthetic depth. However, the patients participating in this study appeared well-anesthetized (using blood pressure, heart rate, and absence of movement as criteria). The MAC of isoflurane increases only -5%l"C central body temperature (24); it is therefore unlikely that sweating resulted from inadequate anesthesia. Thiopental and fentanyl are short-acting drugs and probably did not significantly increase the sweating threshold more than 2 h after they were administered. None of the drugs used in these patients is likely to directly inhibit the postganglionic, cholinergic, sympathetic nerves that mediate thermoregulatory eccrine sweating (25) .
All the patients in this study were young and relatively healthy; it is likely that sweating thresholds differ at the extremes of age and in patients with severe systemic illness. Sweat production is normally a function of both central and skin-surface temperature (10, 11, 26) . The threshold during isoflurane anesthesia may, therefore, be higher when skin temperature remains relatively low. However, we have previously demonstrated that the sweating threshold also is -38°C during rewarming by cardiopulmonary bypass in patients given high-dose opioids (27) .
In summary, isoflurane anesthesia in humans markedly decreases the threshold temperature triggering peripheral thermoregulatory vasoconstriction (i.e., central temperature triggering vasoconstriction). However, it is not known whether the sweating threshold remains unchanged (e.g., near 37"C), decreases along with the vasoconstriction threshold, or increases during anesthetic administration. Accordingly, the author tested the hypothesis that isoflurane anesthesia increases the thermoregulatory threshold for sweating. Forehead sweating was evaluated in five healthy patients given isoflurane anesthesia. The sweating threshold was prospectively defined as the distal esophageal temperature at which significant sweating was first observed. Sweating was observed in each patient at a mean central temperature of 38.3 ? 0.3"C and an end-tidal isoflurane concentration of 1.1% t 0.2%. The interthreshold range (difference between vasoconstriction and sweating thresholds) without anesthesia is -0.5"C; isoflurane anesthesia increases this range to -4°C. ANESTH ANALG 1991; 73:300-3 The assistance and encouragement of Leonard Gordon, MD, is greatly appreciated. The thermometers and thermocouples used were generously donated by Mon-a-Therm Inc. Datex Medical Instrumentation, Inc., provided the Datex Capnomac on loan.
